HURA
TuHURA Biosciences, Inc.NASDAQHealthcare$1.41-12.96%ClosedMarket Cap: $79.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.32
P/S
0.00
EV/EBITDA
0.00
DCF Value
$0.07
FCF Yield
-50.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-179.4%
ROA
-109.9%
ROIC
0.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $23.6M | $-6.8M | $-0.13 | — |
| FY 2025 | $0.00 | NaN% | $0.00 | $-30.1M | $-0.63 | — |
| Q3 2025 | $0.00 | NaN% | $-6.7M | $-7.1M | $-0.14 | — |
| Q2 2025 | $0.00 | NaN% | $-9.9M | $-9.5M | $-0.21 | — |
| Q1 2025 | $0.00 | NaN% | $-7.0M | $-6.7M | $-0.15 | — |
| Q4 2024 | $0.00 | -Infinity% | $-5.7M | $-6.0M | $-0.14 | — |
| FY 2024 | $0.00 | NaN% | $-17.6M | $-21.7M | $-1.21 | — |
| Q3 2024 | $0.00 | NaN% | $-2.2M | $-2.2M | $-3.00 | — |
| Q2 2024 | $0.00 | NaN% | $-3.6M | $-5.3M | $-1.47 | — |
| Q1 2024 | $0.00 | NaN% | $-4.6M | $-4.8M | $-13.92 | — |
| Q4 2023 | $0.00 | -Infinity% | $-1.0M | $-1.0M | $-8.27 | — |
| FY 2023 | $0.00 | NaN% | $-29.8M | $-29.3M | $-11.29 | — |